Clinical Trial Update: Adiponectin and Circulating Progenitor Cells (CPC) Function [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating adiponectin and circulating progenitor cell function in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Leipzig | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED